MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):